Successful treatment of field cancerization on the dorsum of the hands with 1% tirbanibulin ointment
Clinical and Experimental Dermatology · 2023
DOI: 10.1093/ced/llad171 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Carlos Abril-Pérez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Dermatology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain. Hauptthemen laut MEDLINE: Keratosis, Actinic, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
The management of actinic keratoses and field cancerization is a therapeutic challenge. Tirbanibulin 1% ointment is a promising new drug for use on specific parts of the body or in patients who are refractory or reluctant to use other more aggressive treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Dermatology Department, Hospital Universitario y Politécnico La Fe, Valencia, Spain.
- Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain.
- Dermatology, Universitat de València, Valencia, Spain.
ORCID-Profile: Carlos Abril-Pérez, Miguel Mansilla-Polo
Zitieren
APA
Abril-Pérez, C., Mansilla-Polo, M., Martin-Torregrosa, D., & Botella-Estrada, R. (2023). Successful treatment of field cancerization on the dorsum of the hands with 1% tirbanibulin ointment. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llad171
Vancouver
Abril-Pérez C, Mansilla-Polo M, Martin-Torregrosa D, Botella-Estrada R. Successful treatment of field cancerization on the dorsum of the hands with 1% tirbanibulin ointment. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llad171
BibTeX
@article{AbrilPrez2023,
author = {Abril-Pérez, Carlos and Mansilla-Polo, Miguel and Martin-Torregrosa, Daniel and Botella-Estrada, Rafael},
title = {Successful treatment of field cancerization on the dorsum of the hands with 1% tirbanibulin ointment},
journal = {Clinical and Experimental Dermatology},
year = {2023},
doi = {10.1093/ced/llad171}
}
EUVIMED